Prophase Labs Stock Price Prediction

PRPH Stock  USD 0.26  0.02  8.33%   
The relative strength index (RSI) of ProPhase Labs' share price is below 30 as of 6th of February 2025 indicating that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling ProPhase Labs, making its price go up or down.

Oversold Vs Overbought

29

 
Oversold
 
Overbought
The successful prediction of ProPhase Labs' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with ProPhase Labs, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting ProPhase Labs' stock price prediction:
Quarterly Earnings Growth
(0.95)
EPS Estimate Next Quarter
0.09
EPS Estimate Current Year
(1.23)
EPS Estimate Next Year
(0.80)
Wall Street Target Price
21
Using ProPhase Labs hype-based prediction, you can estimate the value of ProPhase Labs from the perspective of ProPhase Labs response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in ProPhase Labs to buy its stock at a price that has no basis in reality. In that case, they are not buying ProPhase because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

ProPhase Labs after-hype prediction price

    
  USD 0.26  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out ProPhase Labs Basic Forecasting Models to cross-verify your projections.
For more detail on how to invest in ProPhase Stock please use our How to Invest in ProPhase Labs guide.
Intrinsic
Valuation
LowRealHigh
0.244.8212.91
Details
1 Analysts
Consensus
LowTargetHigh
16.8418.5020.54
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.31-0.31-0.31
Details

ProPhase Labs After-Hype Price Prediction Density Analysis

As far as predicting the price of ProPhase Labs at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ProPhase Labs or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ProPhase Labs, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

ProPhase Labs Estimiated After-Hype Price Volatility

In the context of predicting ProPhase Labs' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ProPhase Labs' historical news coverage. ProPhase Labs' after-hype downside and upside margins for the prediction period are 0.01 and 8.35, respectively. We have considered ProPhase Labs' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.26
0.26
After-hype Price
8.35
Upside
ProPhase Labs is very risky at this time. Analysis and calculation of next after-hype price of ProPhase Labs is based on 3 months time horizon.

ProPhase Labs Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as ProPhase Labs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ProPhase Labs backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ProPhase Labs, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  1.48 
8.09
 0.00  
 0.00  
0 Events / Month
0 Events / Month
Within a week
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.26
0.26
0.00 
0.00  
Notes

ProPhase Labs Hype Timeline

ProPhase Labs is at this time traded for 0.26. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. ProPhase is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at -1.48%. %. The volatility of related hype on ProPhase Labs is about 1213500.0%, with the expected price after the next announcement by competition of 0.26. About 14.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.19. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. ProPhase Labs recorded a loss per share of 1.53. The entity last dividend was issued on the 24th of May 2022. The firm had 2:1 split on the 23rd of January 1997. Given the investment horizon of 90 days the next projected press release will be within a week.
Check out ProPhase Labs Basic Forecasting Models to cross-verify your projections.
For more detail on how to invest in ProPhase Stock please use our How to Invest in ProPhase Labs guide.

ProPhase Labs Related Hype Analysis

Having access to credible news sources related to ProPhase Labs' direct competition is more important than ever and may enhance your ability to predict ProPhase Labs' future price movements. Getting to know how ProPhase Labs' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ProPhase Labs may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
LMDXLumiraDx 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
STRRStar Equity Holdings 0.00 0 per month 0.00 (0.26) 5.56 (5.70) 17.14 
ENZEnzo Biochem 0.00 0 per month 0.00 (0.18) 6.12 (4.76) 36.82 
GTHGenetron Holdings 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
STIMNeuronetics 0.00 0 per month 8.54  0.22  18.50 (9.45) 45.93 
INBSIntelligent Bio Solutions 0.00 0 per month 4.42  0.03  11.39 (7.97) 25.25 
BDSXBiodesix 0.00 0 per month 0.00 (0.08) 8.27 (8.87) 29.63 
PRPOPrecipio 0.00 0 per month 2.56  0.07  5.85 (3.87) 11.89 
DRIODarioHealth Corp 0.01 6 per month 9.50  0.01  12.86 (13.10) 121.18 
OLKOlink Holding AB 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
XGNExagen Inc 0.00 0 per month 5.55  0.16  21.04 (9.13) 45.67 
SHCSotera Health Co 0.00 0 per month 0.00 (0.14) 3.30 (3.17) 6.91 
BNRBurning Rock Biotech 0.00 0 per month 4.86  0.18  16.01 (7.92) 46.14 
PMDPsychemedics 0.00 0 per month 4.62  0.09  6.69 (1.84) 57.47 
SERASera Prognostics 0.00 0 per month 0.00 (0.07) 8.00 (8.66) 33.33 

ProPhase Labs Additional Predictive Modules

Most predictive techniques to examine ProPhase price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ProPhase using various technical indicators. When you analyze ProPhase charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About ProPhase Labs Predictive Indicators

The successful prediction of ProPhase Labs stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ProPhase Labs, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ProPhase Labs based on analysis of ProPhase Labs hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ProPhase Labs's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ProPhase Labs's related companies.
 2022 2024 (projected)
Dividend Yield0.120.14
Price To Sales Ratio0.621.01

Story Coverage note for ProPhase Labs

The number of cover stories for ProPhase Labs depends on current market conditions and ProPhase Labs' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ProPhase Labs is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ProPhase Labs' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

ProPhase Labs Short Properties

ProPhase Labs' future price predictability will typically decrease when ProPhase Labs' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ProPhase Labs often depends not only on the future outlook of the potential ProPhase Labs' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ProPhase Labs' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding17.2 M
Cash And Short Term Investments4.7 M

Complementary Tools for ProPhase Stock analysis

When running ProPhase Labs' price analysis, check to measure ProPhase Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProPhase Labs is operating at the current time. Most of ProPhase Labs' value examination focuses on studying past and present price action to predict the probability of ProPhase Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProPhase Labs' price. Additionally, you may evaluate how the addition of ProPhase Labs to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance